PRA Expands into New Zealand

Wednesday, April 21, 2010 09:15 AM

PRA International expanded its Asia-Pacific operations into New Zealand, hiring staff there and establishing a legal entity. The New Zealand staff will work closely with PRA’s office in Sydney, Australia. New Zealand is a key research location for studies in skin cancer, multiple sclerosis, and asthma, the CRO said. The country is known for high recruitment rates, an efficient regulatory environment and counter seasonality—which is advantageous to influenza and allergy studies.

"We are very pleased with the expansion to New Zealand," noted Edward Ian, PRA's Senior Director of Operations for Asia-Pacific.  "It continues our expansion in this critical region and is an ideal complement to our operations in Australia."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs